TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas
Kun Wang(Chinese Academy of Sciences), Dawei Xu(Karolinska University Hospital), Chang Wang(Allen Institute for Brain Science), Tiantian Liu(Zhengzhou University of Aeronautics), Cheng Liu(Xinjiang Medical University), Nan Ge(Second Hospital of Shandong University), Keqiang Yan(Qilu Hospital of Shandong University), Jikai Liu(Qilu Hospital of Shandong University), Yidong Fan(Guangxi University), Hongbo Ren(Qilu Hospital of Shandong University), Sanyuan Hu(Shandong University), Li Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Magnus Björkholm(Karolinska Institutet)
Cited by 86
Related Papers
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
|Cancer Communications|2021|657
Lipids and Lipid Derivatives for RNA Delivery
|Chemical Reviews|2021|592
Large-Area, Flexible, Transparent, and Long-Lived Polymer-Based Phosphorescence Films
|Journal of the American Chemical Society|2021|513
Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players
|Oncogene|2019|465
ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer
|Journal of Experimental & Clinical Cancer Research|2022|433